Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|September 28, 2011
The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamideMariano F Zacarías Fluck, Leonardo Hess, Mariana Salatino, et al.
Pharmacological Research|February 9, 2016
Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweetPablo F Hockl, Alejandro Wolosiuk, Juan M Pérez-Sáez, et al.
Journal of Extracellular Vesicles|June 5, 2023
Extracellular vesicles from human plasma dampen inflammation and promote tissue repair functions in macrophagesAlan M Adamczyk, María Luz Leicaj, Martina Paula Fabiano, et al.
International Journal of Molecular Sciences|January 11, 2022
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in GlioblastomaGuillermo A Videla-Richardson, Olivia Morris-Hanon, Nicolás I Torres, et al.
Journal of Leukocyte Biology|November 30, 2011
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expressionLucas E Rossi, Damián E Avila, Raúl G Spallanzani, et al.
Angiogenesis|October 2, 2020
Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activitiesJuan M Pérez Sáez, Pablo F Hockl, Alejando J Cagnoni, et al.
Nature Immunology|June 26, 2007
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell deathMarta A Toscano, Germán A Bianco, Juan M Ilarregui, et al.
Hepatology (Baltimore, Md.)|March 11, 2011
Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growthMaría V Espelt, Diego O Croci, María L Bacigalupo, et al.
Pageof 7